These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21450562)
1. Medical and pharmacological direct costs of a 9-week smoking cessation programme. Wasserfallen JB; Digon P; Cornuz J Eur J Prev Cardiol; 2012 Jun; 19(3):565-70. PubMed ID: 21450562 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support. Higashi H; Barendregt JJ Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602 [TBL] [Abstract][Full Text] [Related]
4. Implementing a hospital-based smoking cessation programme: evidence for a learning effect. Raupach T; Shahab L; Neubert K; Felten D; Hasenfuss G; Andreas S Patient Educ Couns; 2008 Feb; 70(2):199-204. PubMed ID: 18031972 [TBL] [Abstract][Full Text] [Related]
5. Randomised trial of two nicotine patch protocols distributed through a state quitline. Burns EK; Hood NE; Goforth E; Levinson AH Tob Control; 2016 Mar; 25(2):218-23. PubMed ID: 25416755 [TBL] [Abstract][Full Text] [Related]
6. Improving the effectiveness of smoking cessation in primary care: lessons learned. Richards D; Toop L; Brockway K; Graham S; McSweeney B; MacLean D; Sutherland M; Parsons A N Z Med J; 2003 May; 116(1173):U417. PubMed ID: 12740611 [TBL] [Abstract][Full Text] [Related]
7. Establishment and evaluation of a smoking cessation clinic in Hong Kong: a model for the future service provider. Abdullah AS; Hedley AJ; Chan SS; Ho WW; Lam TH; J Public Health (Oxf); 2004 Sep; 26(3):239-44. PubMed ID: 15454590 [TBL] [Abstract][Full Text] [Related]
8. Identification of barriers that impede the implementation of nicotine replacement therapy in the acute cardiac care setting. May FC; Stocks N; Barton C Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):646-50. PubMed ID: 18779735 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pharmacotherapy in behavioural therapeutic smoking cessation programmes. Oostveen R; van der Galiƫn OP; Smeets HM; Hollinga AP; Bosmans JE Eur J Public Health; 2015 Apr; 25(2):204-9. PubMed ID: 25477132 [TBL] [Abstract][Full Text] [Related]
10. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG; Gitchell JG; Shiffman S; Sembower MA Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [TBL] [Abstract][Full Text] [Related]
11. The number of smokers needed to screen and treat in a smoking cessation programme. Storm-Versloot MN; Vermeulen H; Wiggers LC; Smets EM; de Haes HC; Peters RJ; Legemate DA; de Vos R Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):669-76. PubMed ID: 19738472 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Chan SS; Leung DY; Abdullah AS; Wong VT; Hedley AJ; Lam TH Addiction; 2011 Jun; 106(6):1155-63. PubMed ID: 21226883 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany. Aumann I; Treskova M; Hagemann N; von der Schulenburg JM Appl Health Econ Health Policy; 2016 Aug; 14(4):441-452. PubMed ID: 27021824 [TBL] [Abstract][Full Text] [Related]
14. A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial. Wolfenden L; Wiggers J; Knight J; Campbell E; Rissel C; Kerridge R; Spigelman AD; Moore K Anaesthesia; 2005 Feb; 60(2):172-9. PubMed ID: 15644016 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of selectors of nicotine replacement therapy. Shiffman S; Di Marino ME; Sweeney CT Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986 [TBL] [Abstract][Full Text] [Related]
16. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Becker KM; Rose JE; Albino AP Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723 [TBL] [Abstract][Full Text] [Related]
18. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. McAfee TA; Bush T; Deprey TM; Mahoney LD; Zbikowski SM; Fellows JL; McClure JB Am J Prev Med; 2008 Aug; 35(2):103-10. PubMed ID: 18617079 [TBL] [Abstract][Full Text] [Related]
19. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05. Lutsenko H; Doran CM; Hall WD Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876 [TBL] [Abstract][Full Text] [Related]
20. Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]